By blocking certain neurogenic changes that occur in the lungs at childhood, patients may avoid asthma and allergic responses into adulthood. At the American Academy of Allergy, Asthma & Immunology Annual Meeting (AAAAI) 2022, clinicians from across the country have gathered to discuss new approaches to asthma and allergy management. Dr. Xingbin Ai, PhD, from Boston University School of Medicine, approaches pediatric care from a unique perspective. She hopes to change the general perspective on how nerves influence asthma and allergies in pediatric patients. She added that with the new development of neutralizing antibodies, pediatric patients can be administered treatment that is safer than general anti-inflammatory drugs. Further research is needed to test these targeted drugs, but the versatility of the lung . . .
Read more at www.hcplive.com
